More effective therapeutic targeting of high risk childhood cancer: Neuroblastoma as a model [ 2018 - ]

Research Grant

Researchers: Prof Michelle Haber (Principal investigator) ,  Prof Glenn Marshall ,  Prof Murray Norris

Brief description Cancer is the commonest cause of death from disease in Australian children. Childhood neuroblastoma is a particularly aggressive cancer, for which new treatment approaches are urgently needed. The team aims to discover better safer therapies for children with this cancer, conducting clinical trials using new drugs and novel drug combinations. We will also investigate novel ways of targeting neuroblastoma cells and identify therapeutic targets in neuroblastoma-initiating cells.

Funding Amount $6,601,220.00

Funding Scheme Programs

Notes Program Grant